Made with FlowPaper - Flipbook Maker
medhealthoutlook.com CRO Edition Reoptimizing Next-Gen Healthcare Outcomes Innovators Medhealth Outlook 2021 CRO Jamie Macdonald, CEO DEC 2021 Liran Hagbi, CEO The Art Of Dentistry: Noris Medical OF THE YEAR Company Copyright @2021 Medhealth Outlook. All Rights Reserved. The content and images used in the publication should not be reproduced or transmitted in any form or by any means without the prior permission of Medhealth Outlook. Monica Philip Joseph Morgan Visualizers editor@medhealthoutlook.com Richard Taylor Dave WalkerSam Morris Editorial staffs Natasha Jacob Managing Editor DEC 2021 Copyright @ Medhealth Outlook 2021 Subscribe medhealthoutlook.com Since the past few years, the global healthcare market has been observing high investments in clinical research and life sciences due to the rising healthcare requirements and modern trends. This factor, alongside the growing demand for clinical trials and quality auditing worldwide, will increase the need for different types of contract research organizations in years to come. The growing demand for effective drugs and a more solid healthcare process is making considerable changes in the industry. Many technological advancements and innovations are also fueling this transformation, making CRO to be more powerful. With differentiation among CROs becoming increasingly blurred, top performers are driving to augment the ability to better leverage data for site selection, enrollment, and commerciality, with an eye to competitive positioning. At this juncture, there is a lot of noise around the CRO space, and businesses are more prone to errors. This is where the role of Medhealth Outlook Magazine comes into the picture. In this special edition, we have included some of the top CRO solution providers, innovators, and businesses that stand out from the crowd. This way, our readers and healthcare experts, as well as businesses looking for the right CRO solution providers, will be able to find their perfect partner. We hope this edition adds value to your CRO initiatives. Editors Note Fulfill the Demanding Drug Development Programs Natasha Jacob Managing Editor Sam Morris Sales sam@medhealthoutlook.com sales@medhealthoutlook.com08 COVER STORY 18222630 Health, Healing and Hope Turning Services into Solutions Outstanding outcomes through Revenue Cycle Management Global Contract Research Organization for Full- Service Drug Development ACM GLOBAL LABORATORIES FRONTAGEINNOVADERM LINICAL Brian Wright, President Dr. Song Li, Chairman & CEO Dr. Robert Bissonnette, Founder & CEO Vita Lanoce, CEO Reoptimizing Next-Gen Healthcare Outcomes Jamie Macdonald, CEO Innovators Medhealth Outlook CRO 2021Contents 24 28 THE VALUE OF ESOURCE AND ELECTRONIC HEALTH RECORD INTEGRATION TO DRIVE CLINICAL TRIAL PARTICIPATION CAN PATIENT CARE BE ADVANCED BY COMMUNITY BASED CLINICAL TRIALS? DIVERSITY AND INCLUSION IN CLINICAL TRIALS NOTHING ABOUT YOU WITHOUT YOU THE BEST APPROACH TO DIGITALIZING CLINICAL STUDIES 28 DATA IS THE NEW FUEL FOR EFFECTIVE PATIENT ADVOCACY Donna Cryer, President & CEO, Global Liver Institute Kent Thoelke, Chief Innovation Officer, ICONplc By Deepak Behera, President & CEO, Adaptive Research Diana Foster, CEO, Total Diversity Clinical Trials Management Julie Jacobsen, Communication Manager, Studiesandme 3438 Accelerating Pharma Breakthroughs with Integrated, Multiomic, Single Cell Services Driving Clinical Research Innovation SIRONA DXTECHNICAL RESOURCES INTERNATIONAL : Andrew Brown PhD, Chief Commercial Officer Nora Lee, TRI President and CEO Liran Hagbi, CEO The Art Of Dentistry: Noris Medical OF THE YEAR Company 16 36 20Innovators Medhealth Outlook 2021 CRO Jamie Macdonald, CEOO ver the years, technology, innovations and dedicated experts have been trying to change the way clinical trial works. As a result of their dedication and work, the future of clinical trials is now. Organizations like Parexel International—a company that provides services to help life sciences and biopharmaceutical clients transform scientific discoveries into new treatment—are committed to creating innovations that make this research accessible to more people. Headquartered in Massachusetts, US, the company has been privately owned by Pamplona Capital Management since 2017. It partners with drug Reoptimizing Next-Gen Healthcare Outcomes Next >